J.J.P. Kastelein has published from 2000 upto 2013 at (or in association with) the University of Amsterdam (as found in the CRIS of the UvA for the years 2000 upto 2015 ) a total of 535 publications. The above histogram shows the different types and number of publications for this whole publication period at the University of Amsterdam. You can download the information depicted in the histogram by following the link below.Complete publication type list A picture is worth a thousand words, but the above histogram can be described by the following words: (not thousand but around 125 words, click 'view' button to show those words).View
In 2000 J.J.P. Kastelein published twenty-six articles and published one chapter. In 2001 J.J.P. Kastelein published twenty-seven articles, published one book editorship, published one other results and published one chapter. In 2002 J.J.P. Kastelein published thirty-four articles and published one book editorship. In 2003 J.J.P. Kastelein published fourty-six articles. In 2004 J.J.P. Kastelein published fifty-eight articles, published one book editorship and published one chapter. In 2005 J.J.P. Kastelein published seventy-four articles. In 2006 J.J.P. Kastelein published thirty-seven articles. In 2007 J.J.P. Kastelein published fourty-four articles. In 2010 J.J.P. Kastelein published fifty-five articles. In 2011 J.J.P. Kastelein published fourty-three articles. In 2012 J.J.P. Kastelein published fourty-eight articles. In 2013 J.J.P. Kastelein published thirty-six articles.
We did find some data on societal impact for J.J.P. Kastelein on altmetric.com. Data are collected on altmetic.com (September 2015) based on publications found in the CRIS of the UvA (march 2015 update). Only publications in 2013 and 2014 are harvested.129 mentions of a publication in JAMA (2013). Effect of Aliskiren on Progression of Coronary Disease in Patients With Prehypertension The AQUARIUS Randomized Clinical Trial Link to altmetric.com. 122 mentions of a publication in Nature genetics (2013). Common variants associated with plasma triglycerides and risk for coronary artery disease Link to altmetric.com. 82 mentions of a publication in Nature genetics (2013). Discovery and refinement of loci associated with lipid levels Link to altmetric.com. 55 mentions of a publication in Human Gene Therapy (2013). From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world Link to altmetric.com. 26 mentions of a publication in Circulation (2013). High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect Link to altmetric.com. 15 mentions of a publication in Circulation (2013). Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis Link to altmetric.com. 11 mentions of a publication in European Heart journal (2013). Diagnosis and treatment of familial hypercholesterolaemia Link to altmetric.com. 6 mentions of a publication in European Heart journal (2013). Clinical implications of JUPITER in a contemporary European population: the EPIC-Norfolk prospective population study Link to altmetric.com. 4 mentions of a publication in European Heart journal (2013). C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care Link to altmetric.com. 4 mentions of a publication in Diabetes & Vascular Disease Research (2013). Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial Link to altmetric.com. 3 mentions of a publication in Cardiovascular diabetology (2013). Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200--500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study Link to altmetric.com. 2 mentions of a publication in Arteriosclerosis, thrombosis and vascular biology (2013). C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study Link to altmetric.com. 2 mentions of a publication in European journal of clinical investigation (2013). Non-HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study Link to altmetric.com. 2 mentions of a publication in Current Opinion in Lipidology (2013). introduction Link to altmetric.com. 2 mentions of a publication in Arteriosclerosis, thrombosis and vascular biology (2013). Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia Link to altmetric.com. 2 mentions of a publication in Human Molecular Genetics (2013). Loci influencing blood pressure identified using a cardiovascular gene-centric array Link to altmetric.com. 1 mentions of a publication in Journal of Lipid Research (2013). In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1 Link to altmetric.com. 1 mentions of a publication in International Journal of Cardiology (2013). Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels Link to altmetric.com. 1 mentions of a publication in European Heart journal (2013). ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden Link to altmetric.com. 1 mentions of a publication in Journal of the American College of Cardiology (2013). Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes Link to altmetric.com. 1 mentions of a publication in European Heart journal (2013). Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein Link to altmetric.com. 1 mentions of a publication in Current Opinion in Lipidology (2013). Recent failures in antiatherosclerotic drug development: examples from the thyroxin receptor agonist, the secretory phospholipase A2 antagonist, and the acyl coenzyme A: cholesterol acyltransferase inhibitor programs Link to altmetric.com. 1 mentions of a publication in Drugs (2013). LDL cholesterol goals in high-risk patients: how low do we go and how do we get there? Link to altmetric.com. 1 mentions of a publication in Circulation. Cardiovascular genetics (2013). The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans Link to altmetric.com. 29 works in 47 publications in 3 languages and 546 library holdings Complete co-author list Complete publisher list J.J.P. Kastelein published from 2000 upto 2015 a total of 528 UvA-articles with 50 or less co-authors.1747 unique co-authors in total with an average of 7.26 co-authors per article.
Professor, Doctor KasteleinFirst name(-s): Johannes Jacob PieterProfessor, Doctor Kastelein obtained his pHd in 1991 (June 6).
Prof.dr. J.J.P. (John) Kastelein Professor
Genetic aspects of vascular disorders
Visit Narcis profile
Visualization of the write position of the 528 journal publications by J.J.P. Kastelein
|10|| number of times sole author|
|17|| number of times first author|
|27|| number of times second author|
|151|| number of times last author|
The amount of credits for a certain Author position, also called write position, does differ by discipline. Some journals publish author names in alphabetical order. This is common practice by publications with many authors. Time span of publications analysed range from 2000 upto 2015.
The data shown here are based on the publications of the UvA-CRIS (May 2016) and the citations found in WoS. The citations to articles are ranked by number of citations. Zero times cited publications are not shown in the diagram. Updated September 5th 2016
26644 (WoS) citations to 430 publications
average 61.96 citations per publication
This functionality is in Alpha phase.